These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7658311)

  • 1. Recombinant erythropoietin for prevention of anemia in preterm infants.
    Obladen M; Maier RF
    J Perinat Med; 1995; 23(1-2):119-26. PubMed ID: 7658311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin to prevent and treat the anemia of prematurity.
    Ohls RK
    Curr Opin Pediatr; 1999 Apr; 11(2):108-14. PubMed ID: 10202619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human recombinant erythropoietin in the prevention and treatment of anemia of prematurity.
    Ohls RK
    Paediatr Drugs; 2002; 4(2):111-21. PubMed ID: 11888358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of erythropoietin on erythrocyte deformability in non-transfused preterm infants.
    Klipp M; Holzwarth AU; Poeschl JM; Nelle M; Linderkamp O
    Acta Paediatr; 2007 Feb; 96(2):253-6. PubMed ID: 17429915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Aher SM; Ohlsson A
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004865. PubMed ID: 16856063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
    Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
    N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant erythropoietin in treatment of the anemia of prematurity.
    Halpérin DS
    Am J Pediatr Hematol Oncol; 1991; 13(3):351-63. PubMed ID: 1793163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.
    Shannon KM; Mentzer WC; Abels RI; Freeman P; Newton N; Thompson D; Sniderman S; Ballard R; Phibbs RH
    J Pediatr; 1991 Jun; 118(6):949-55. PubMed ID: 2040933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early treatment of premature infants with recombinant human erythropoietin.
    Messer J; Haddad J; Donato L; Astruc D; Matis J
    Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of early human recombinant erythropoietin therapy on the transfusion in healthy preterm infants.
    Khatami SF; Mamouri G; Torkaman M
    Indian J Pediatr; 2008 Dec; 75(12):1227-30. PubMed ID: 19057854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential for treatment of anemia of prematurity with recombinant human erythropoietin.
    Phibbs RH
    Curr Opin Pediatr; 1995 Apr; 7(2):140-5. PubMed ID: 7787927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin therapy for extremely premature infants.
    Phibbs RH
    J Perinat Med; 1995; 23(1-2):127-31. PubMed ID: 7658312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low and moderate doses of recombinant human erythropoietin on the haematological response in premature infants on a high protein and iron intake.
    Bechensteen AG; Hågå P; Halvorsen S; Liestøl K; Lindemann R; Whitelaw A; Tølløfsrud PA; Daae L; Thorstensen K; Sundal E
    Eur J Pediatr; 1997 Jan; 156(1):56-61. PubMed ID: 9007493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity.
    Soubasi V; Kremenopoulos G; Diamanti E; Tsantali C; Sarafidis K; Tsakiris D
    J Pediatr; 1995 Aug; 127(2):291-7. PubMed ID: 7636658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia of prematurity: the prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin.
    Dallman PR
    Adv Pediatr; 1993; 40():385-403. PubMed ID: 8249712
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythropoietin and neonatal anemia.
    Strauss RG
    N Engl J Med; 1994 Apr; 330(17):1227-8. PubMed ID: 8139633
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythropoietin (Epo), protein and iron supplementation and the prevention of anaemia of prematurity: effects on serum immunoreactive Epo, growth and protein and iron metabolism.
    Bechensteen AG; Halvorsen S; Hågå P; Cotes PM; Liestøl K
    Acta Paediatr; 1996 Apr; 85(4):490-5. PubMed ID: 8740312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.
    Ohls RK; Christensen RD
    J Pediatr; 1991 Nov; 119(5):781-8. PubMed ID: 1941387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.